69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes
Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system. IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used...
Gespeichert in:
| Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2020-06, Vol.69 (Supplement_1) |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_1 |
| container_start_page | |
| container_title | Diabetes (New York, N.Y.) |
| container_volume | 69 |
| creator | BERGENSTAL, RICHARD M. KERR, MATTHEW S.D. ROBERTS, GREGORY J. SOUTO, DIANA NABUTOVSKY, YELENA HIRSCH, IRL B. |
| description | Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system.
IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used in this retrospective, observational analysis. MarketScan contains insurance billing claims for inpatient, outpatient, and pharmacy expenses. Cohort requirements included: de novo FreeStyle Libre system purchase in 2017 Q4-2018 Q2, diagnosis of T2D, ≥18 years old, fast- or short-acting insulin, and ≥6-months pre-CGM observation time. Primary outcome was acute diabetes events (ADE): hospitalization with hyper-/hypoglycemia as the primary diagnosis or outpatient emergency associated with a code of hyper-/hypoglycemia. Secondary outcome was all-cause hospitalizations. Andersen-Gill Cox regression compared event rates 6-months pre-/post-CGM.
The cohort (n=1,244, age 53.6±9.7 years, 53.8% male) experienced a reduction in ADE from 0.158 to 0.077 events/patient-year (HR: 0.49 [0.34 0.69]; P: |
| doi_str_mv | 10.2337/db20-69-OR |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2419453619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2419453619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1049-5e7a600ece4b7016782c3f21a4e92e56ebdecfbd44f52bdf3d441aec1be9e9bd3</originalsourceid><addsrcrecordid>eNo9kd1Kw0AQhRdRsFZvfIIF74To_uTH9a7U1hYKldqCd2F3M9EtaRJ3N0p8NJ_OpFWZi5lhDt-BMwhdUnLDOE9uM8VIEItguTpCAyq4CDhLXo7RgBDKApqI5BSdObclhMRdDdD3XnyPpxbA-bYAvDDKAn5unYcd3jjAc4dHzlXaSA8Z_jT-Da8ga7Q3VYlNiedlLb2B0mNZZnjZ-L91sgP7CqVu8Ug3HvCDkQo8ODz56M5uLx8VRTCWTWczq1xtvCzMl-zJrkc_HUju4Lpua8DsH3OOTnJZOLj47UO0mU7W41mwWD7Ox6NFoCkJRRBBImNCQEOoEkLj5I5pnjMqQxAMohhUBjpXWRjmEVNZzruJStBUgQChMj5EVwdubav3pksp3VaNLTvLlIVUhBGPu6SH6Pqg0rZyzkKe1tbspG1TStL-N2n_mzQW6XLFfwCBzIU2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419453619</pqid></control><display><type>article</type><title>69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes</title><source>PMC (PubMed Central)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BERGENSTAL, RICHARD M. ; KERR, MATTHEW S.D. ; ROBERTS, GREGORY J. ; SOUTO, DIANA ; NABUTOVSKY, YELENA ; HIRSCH, IRL B.</creator><creatorcontrib>BERGENSTAL, RICHARD M. ; KERR, MATTHEW S.D. ; ROBERTS, GREGORY J. ; SOUTO, DIANA ; NABUTOVSKY, YELENA ; HIRSCH, IRL B.</creatorcontrib><description>Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system.
IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used in this retrospective, observational analysis. MarketScan contains insurance billing claims for inpatient, outpatient, and pharmacy expenses. Cohort requirements included: de novo FreeStyle Libre system purchase in 2017 Q4-2018 Q2, diagnosis of T2D, ≥18 years old, fast- or short-acting insulin, and ≥6-months pre-CGM observation time. Primary outcome was acute diabetes events (ADE): hospitalization with hyper-/hypoglycemia as the primary diagnosis or outpatient emergency associated with a code of hyper-/hypoglycemia. Secondary outcome was all-cause hospitalizations. Andersen-Gill Cox regression compared event rates 6-months pre-/post-CGM.
The cohort (n=1,244, age 53.6±9.7 years, 53.8% male) experienced a reduction in ADE from 0.158 to 0.077 events/patient-year (HR: 0.49 [0.34 0.69]; P:<0.001). Hospitalizations also reduced from 0.345 to 0.247 events/patient-year (HR: 0.72 [0.58 0.88]; P:0.002).
After FreeStyle Libre system purchase, T2D patients had lower rates of ADE and all-cause hospitalizations.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db20-69-OR</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Blood glucose ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diagnosis ; Glucose monitoring ; Hospitalization ; Hypoglycemia ; Insulin</subject><ispartof>Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)</ispartof><rights>Copyright American Diabetes Association Jun 1, 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1049-5e7a600ece4b7016782c3f21a4e92e56ebdecfbd44f52bdf3d441aec1be9e9bd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>BERGENSTAL, RICHARD M.</creatorcontrib><creatorcontrib>KERR, MATTHEW S.D.</creatorcontrib><creatorcontrib>ROBERTS, GREGORY J.</creatorcontrib><creatorcontrib>SOUTO, DIANA</creatorcontrib><creatorcontrib>NABUTOVSKY, YELENA</creatorcontrib><creatorcontrib>HIRSCH, IRL B.</creatorcontrib><title>69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes</title><title>Diabetes (New York, N.Y.)</title><description>Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system.
IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used in this retrospective, observational analysis. MarketScan contains insurance billing claims for inpatient, outpatient, and pharmacy expenses. Cohort requirements included: de novo FreeStyle Libre system purchase in 2017 Q4-2018 Q2, diagnosis of T2D, ≥18 years old, fast- or short-acting insulin, and ≥6-months pre-CGM observation time. Primary outcome was acute diabetes events (ADE): hospitalization with hyper-/hypoglycemia as the primary diagnosis or outpatient emergency associated with a code of hyper-/hypoglycemia. Secondary outcome was all-cause hospitalizations. Andersen-Gill Cox regression compared event rates 6-months pre-/post-CGM.
The cohort (n=1,244, age 53.6±9.7 years, 53.8% male) experienced a reduction in ADE from 0.158 to 0.077 events/patient-year (HR: 0.49 [0.34 0.69]; P:<0.001). Hospitalizations also reduced from 0.345 to 0.247 events/patient-year (HR: 0.72 [0.58 0.88]; P:0.002).
After FreeStyle Libre system purchase, T2D patients had lower rates of ADE and all-cause hospitalizations.</description><subject>Blood glucose</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diagnosis</subject><subject>Glucose monitoring</subject><subject>Hospitalization</subject><subject>Hypoglycemia</subject><subject>Insulin</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kd1Kw0AQhRdRsFZvfIIF74To_uTH9a7U1hYKldqCd2F3M9EtaRJ3N0p8NJ_OpFWZi5lhDt-BMwhdUnLDOE9uM8VIEItguTpCAyq4CDhLXo7RgBDKApqI5BSdObclhMRdDdD3XnyPpxbA-bYAvDDKAn5unYcd3jjAc4dHzlXaSA8Z_jT-Da8ga7Q3VYlNiedlLb2B0mNZZnjZ-L91sgP7CqVu8Ug3HvCDkQo8ODz56M5uLx8VRTCWTWczq1xtvCzMl-zJrkc_HUju4Lpua8DsH3OOTnJZOLj47UO0mU7W41mwWD7Ox6NFoCkJRRBBImNCQEOoEkLj5I5pnjMqQxAMohhUBjpXWRjmEVNZzruJStBUgQChMj5EVwdubav3pksp3VaNLTvLlIVUhBGPu6SH6Pqg0rZyzkKe1tbspG1TStL-N2n_mzQW6XLFfwCBzIU2</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>BERGENSTAL, RICHARD M.</creator><creator>KERR, MATTHEW S.D.</creator><creator>ROBERTS, GREGORY J.</creator><creator>SOUTO, DIANA</creator><creator>NABUTOVSKY, YELENA</creator><creator>HIRSCH, IRL B.</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20200601</creationdate><title>69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes</title><author>BERGENSTAL, RICHARD M. ; KERR, MATTHEW S.D. ; ROBERTS, GREGORY J. ; SOUTO, DIANA ; NABUTOVSKY, YELENA ; HIRSCH, IRL B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1049-5e7a600ece4b7016782c3f21a4e92e56ebdecfbd44f52bdf3d441aec1be9e9bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Blood glucose</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diagnosis</topic><topic>Glucose monitoring</topic><topic>Hospitalization</topic><topic>Hypoglycemia</topic><topic>Insulin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BERGENSTAL, RICHARD M.</creatorcontrib><creatorcontrib>KERR, MATTHEW S.D.</creatorcontrib><creatorcontrib>ROBERTS, GREGORY J.</creatorcontrib><creatorcontrib>SOUTO, DIANA</creatorcontrib><creatorcontrib>NABUTOVSKY, YELENA</creatorcontrib><creatorcontrib>HIRSCH, IRL B.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BERGENSTAL, RICHARD M.</au><au>KERR, MATTHEW S.D.</au><au>ROBERTS, GREGORY J.</au><au>SOUTO, DIANA</au><au>NABUTOVSKY, YELENA</au><au>HIRSCH, IRL B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2020-06-01</date><risdate>2020</risdate><volume>69</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system.
IBM MarketScan™ Commercial Claims and Medicare Supplemental databases were used in this retrospective, observational analysis. MarketScan contains insurance billing claims for inpatient, outpatient, and pharmacy expenses. Cohort requirements included: de novo FreeStyle Libre system purchase in 2017 Q4-2018 Q2, diagnosis of T2D, ≥18 years old, fast- or short-acting insulin, and ≥6-months pre-CGM observation time. Primary outcome was acute diabetes events (ADE): hospitalization with hyper-/hypoglycemia as the primary diagnosis or outpatient emergency associated with a code of hyper-/hypoglycemia. Secondary outcome was all-cause hospitalizations. Andersen-Gill Cox regression compared event rates 6-months pre-/post-CGM.
The cohort (n=1,244, age 53.6±9.7 years, 53.8% male) experienced a reduction in ADE from 0.158 to 0.077 events/patient-year (HR: 0.49 [0.34 0.69]; P:<0.001). Hospitalizations also reduced from 0.345 to 0.247 events/patient-year (HR: 0.72 [0.58 0.88]; P:0.002).
After FreeStyle Libre system purchase, T2D patients had lower rates of ADE and all-cause hospitalizations.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db20-69-OR</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-1797 |
| ispartof | Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1) |
| issn | 0012-1797 1939-327X |
| language | eng |
| recordid | cdi_proquest_journals_2419453619 |
| source | PMC (PubMed Central); EZB-FREE-00999 freely available EZB journals |
| subjects | Blood glucose Diabetes Diabetes mellitus (non-insulin dependent) Diagnosis Glucose monitoring Hospitalization Hypoglycemia Insulin |
| title | 69-OR: Freestyle Libre System Use Is Associated with Reduction in Inpatient and Outpatient Emergency Acute Diabetes Events and All-Cause Hospitalizations in Patients with Type 2 Diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A26%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=69-OR:%20Freestyle%20Libre%20System%20Use%20Is%20Associated%20with%20Reduction%20in%20Inpatient%20and%20Outpatient%20Emergency%20Acute%20Diabetes%20Events%20and%20All-Cause%20Hospitalizations%20in%20Patients%20with%20Type%202%20Diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=BERGENSTAL,%20RICHARD%20M.&rft.date=2020-06-01&rft.volume=69&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db20-69-OR&rft_dat=%3Cproquest_cross%3E2419453619%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419453619&rft_id=info:pmid/&rfr_iscdi=true |